Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024 - a sharp decline from the $2.8bn recorded in the ...
Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...
Norovirus infection rates are extremely high this year, raising the question: Why can’t a vaccine protect us from the stomach ...
Kengo Kuma and Associates’ extension to Lisbon’s Centro de Arte Moderna is a gesture that bears no relation to the existing ...
For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...
Is this an opportunity worth hearing about? The post The Cochlear share price hit a 52-week low last week, is it time to buy?
The news: Cochlear shares have mounted a recovery after Friday's slump, boosted by an upgrade from UBS. The numbers: The hearing implant maker's shares were up 2.9% to $270.21 at 1pm AEDT. They closed ...